Imbed Biosciences
Develops advanced synthetic antimicrobial and tissue regeneration solutions for wound care
UndisclosedStrategic
Role not disclosedBH
BioLab Holdings
Activity from announced rounds
Activity in this selectionUnited States · Feb 28, 2026 · Feb 1, 2026
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share